Aspergillus fumigatus infection of an automatic internal cardiac defibrillator.
We report a patient without immune compromise with infection of an automatic internal cardiac defibrillator patch due to Aspergillus fumigatus presenting 8 years after implantation. The mechanism of infection was unknown, but symptoms began 1 month after laser uvulopalatopharyngoplasty was performed for sleep apnea. The patches were surgically removed and the patient was treated sequentially with amphotericin B and itraconazole. He remains without evidence of infection 12 months after the completion of therapy.
Dunn
C J
CJ
Department of Medicine, Sequoia Hospital, Redwood City, California, USA.
Ruder
M
M
Deresinski
S C
SC
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000209:etiology*; D001232:Aspergillus fumigatus; D017147:Defibrillators, Implantable; D006801:Humans; D008297:Male; D016459:Prosthesis-Related Infections
D000935:Antifungal Agents; D000666:Amphotericin B